MedPath

JANSSEN DIAGNOSTICS, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients

Withdrawn
Conditions
Metastatic Breast Cancer
Breast Cancer
First Posted Date
2014-04-10
Last Posted Date
2015-06-19
Lead Sponsor
Janssen Diagnostics, LLC
Registration Number
NCT02111031
Locations
🇺🇸

Thomas Jefferson University, Philadelphia, Pennsylvania, United States

🇺🇸

Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index

Completed
Conditions
Metastatic Breast Cancer
Interventions
Other: Blood collection
First Posted Date
2012-10-04
Last Posted Date
2017-03-08
Lead Sponsor
Janssen Diagnostics, LLC
Target Recruit Count
121
Registration Number
NCT01701050
Locations
🇨🇦

Mt. Sinai Hosp., Marvette Koffler Breast Center, Toronto, Ontario, Canada

🇨🇦

Princess Margaret Hospital, Toronto, Ontario, Canada

🇺🇸

Florida Cancer Specialists, St. Petersburg, Florida, United States

and more 16 locations

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

Terminated
Conditions
Breast Cancer
Interventions
Device: GeneSearchâ„¢ Breast Lymph Node (BLN) Assay
First Posted Date
2008-01-16
Last Posted Date
2016-01-12
Lead Sponsor
Janssen Diagnostics, LLC
Target Recruit Count
233
Registration Number
NCT00595023
Locations
🇺🇸

Georgia Esoteric and Molecular Labs, LLC, Augusta, Georgia, United States

🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

St. Anthony's Hospital, St. Petersburg, Florida, United States

and more 3 locations

GeneSearchâ„¢ Breast Lymph Node (BLN) Assay Post Approval Study

Terminated
Conditions
Breast Cancer
Interventions
Device: GeneSearchâ„¢ Breast Lymph Node (BLN) Assay
First Posted Date
2008-01-16
Last Posted Date
2016-01-12
Lead Sponsor
Janssen Diagnostics, LLC
Target Recruit Count
461
Registration Number
NCT00595296
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

Georgetown University Medical Center, Washington, District of Columbia, United States

🇺🇸

Woman's Hospital, Flowood, Mississippi, United States

and more 3 locations

Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer

Completed
Conditions
Breast Cancer
Interventions
Device: GeneSearchâ„¢ Breast Lymph Node (BLN) Assay
First Posted Date
2007-10-30
Last Posted Date
2016-01-12
Lead Sponsor
Janssen Diagnostics, LLC
Target Recruit Count
80
Registration Number
NCT00551278
Locations
🇺🇸

Indiana University Hospital, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath